SCHEMBL212611

SCHEMBL212611

Oc1nc2c(Cl)nc3ccccc3c2n1Cc1cccnc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 10/20 0.51
SRC P12931 1/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
RAD1 O60671 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CFTR P13569 1/20 0.43
APEX1 P27695 1/20 0.43
CASP6 P55212 1/20 0.43
KMT2A Q03164 1/20 0.43
RAD51 Q06609 1/20 0.43
HKDC1 Q2TB90 1/20 0.43
GOPC Q9HD26 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TLR8 Q9NR97 4/20 0.42
LMNA P02545 1/20 0.39
GBA1 P04062 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211223 0.90 TLR7 (0.51) TLR7TLR8
SCHEMBL211851 0.86 TLR7 (0.67) TLR7TLR8
SCHEMBL212885 0.79 TLR7 (0.53) TLR7MAPTKDM4EALDH1A1KMT2A
SCHEMBL5136457 0.78 TLR7 (0.46) TLR7ALDH1A1TLR8SMN1; SMN2
SCHEMBL213070 0.77 MEN1 (0.43) TLR7MAPTKMT2ATLR8
SCHEMBL211352 0.76 TLR7 (0.71) TLR7TLR8
SCHEMBL9601995 0.75 TLR7 (0.73) TLR7ALDH1A1KMT2ATLR8LMNA
SCHEMBL211357 0.74 TLR7 (0.38) TLR7TLR8
SCHEMBL213639 0.74 TSHR (0.47) TLR7MAPTALDH1A1KMT2ATLR8
Bromide SCHEMBL842506 0.74 TLR7 (0.56) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948173-B1 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS 3M INNOVATIVE PROPERTIES CO (US) 2013-07-17 EP disclosed
US-8377957-B2 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-02-19 US disclosed
US-20120071463-A1 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS 3M INNOVATIVE PROPERTIES COMPANY 2012-03-22 US disclosed
US-8088790-B2 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 US disclosed
US-20090221556-A1 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS PFIZER INC. 2009-09-03 US disclosed
EP-1948173-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS Coley Pharmaceutical Group, Inc. (US) 2008-07-30 EP disclosed
WO-2007056112-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221556-A1 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS IFNG, IL2, IRF3 TLR7 58/4885SRC 1461/4885MAPT 4616/4885
US-20120071463-A1 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS IFNG, IL2, IRF3 TLR7 58/4885SRC 1461/4885MAPT 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.